Mylan NV Ord Shs (MYL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MYL | RDY | BBIO | ||
Company | Mylan NV Ord Shs | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | ||
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | ||
Open | 15.64 | 74.95 | 28.13 | ||
High | 16.15 | 75.18 | 28.28 | ||
Low | 15.34 | 74.90 | 27.61 | ||
Last | 15.86 | 75.09 | 27.88 | ||
Change | +0.31 | -0.12 | +0.05 | ||
% Change | +1.96% | -0.16% | +0.18% | ||
Volume | 26,574,100 | 3,232 | 43,235 | ||
20-Day Average Volume | 8,612,350 | 185,043 | 1,545,927 | ||
Previous Close | 15.55 | 75.21 | 27.83 | ||
Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 15.15 | 72.83 | 26.15 | ||
20-Day Raw Stochastic | 86.27% | 90.56% | 81.57% | ||
20-Day Relative Strength | 55.75% | 56.56% | 50.01% | ||
Weighted Alpha | -23.10 | +32.46 | +13.24 | ||
Today's Opinion | 40% Sell | 88% Buy | 64% Sell | ||
Previous Opinion | 64% Sell | 88% Buy | 64% Sell | ||
Last Month's Opinion | 64% Sell | 40% Buy | 56% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +4.86% since 11/09/20 | +0.76% since 04/29/24 | +9.31% since 04/29/24 | ||
Low | 15.10 on 11/10/20 | 73.38 on 05/01/24 | 24.95 on 04/30/24 | ||
High | 16.15 on 11/16/20 | 75.43 on 05/03/24 | 28.78 on 05/03/24 | ||
1-Month | |||||
%Chg | +0.92% since 10/16/20 | +1.66% since 04/05/24 | -0.93% since 04/05/24 | ||
Low | 14.00 on 10/29/20 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | ||
High | 16.15 on 11/16/20 | 75.43 on 05/03/24 | 28.78 on 05/03/24 | ||
3-Month | |||||
%Chg | -2.07% since 08/14/20 | +2.44% since 02/06/24 | -18.17% since 02/06/24 | ||
Low | 14.00 on 10/29/20 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | ||
High | 17.03 on 08/19/20 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | ||
6-Month | |||||
%Chg | +4.58% since 05/15/20 | +15.82% since 11/06/23 | -0.14% since 11/06/23 | ||
Low | 14.00 on 10/29/20 | 64.50 on 12/11/23 | 23.68 on 04/25/24 | ||
High | 19.24 on 06/08/20 | 77.72 on 02/23/24 | 44.32 on 12/28/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 8,586,212 | 12,550,895 | 5,207,800 | ||
Shares Outstanding, K | 541,546 | 166,878 | 187,129 | ||
Annual Sales | 11,500,500,000 | 2,992,000,000 | 9,300,000 | ||
Annual Net Income | 16,800,000 | 548,000,000 | -643,200,000 | ||
Last Quarter Sales | 2,972,100,000 | 865,780,000 | 1,750,000 | ||
Last Quarter Net Income | 185,700,000 | 165,470,000 | -168,150,000 | ||
60-Month Beta | 1.45 | 0.57 | 1.08 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.36 on 11/06/20 | 0.99 on 01/31/24 | -0.20 on 05/02/24 | ||
Latest Earnings Date | 11/06/20 | 05/07/24 | 05/02/24 | ||
Most Recent Dividend | 0.060 on 06/27/07 | 0.410 on 07/28/23 | N/A | ||
Next Ex-Dividends Date | N/A | 07/28/23 | N/A | ||
Ratios | |||||
Price/Earnings ttm | 3.29 | 19.73 | 0.00 |